Holista Colltech Limited (HCT.AX)
Holista Colltech Limited operates in the Biotechnology industry of the Healthcare sector, headquartered in Subiaco, WA, AU. The stock last traded at $0.05, down 5.66% on the session, giving a market capitalisation of $18.4M. Its beta of 1.33 implies it has historically moved more than the broad market.
Holista CollTech Limited is a biotechnology firm with operations spanning Australia, Malaysia, and the United States. Its business activities are organized into four key divisions: Supplements, Ovine Collagen, Infection Control Solutions, and Food Ingredients. The company specializes in the production and distribution of dietary supplements, cosmetic-quality collagen, and a variety of health-conscious food ingredients. These innovative food products include low-glycemic index (GI) flour blends suitable for noodles, pasta, flatbreads, and other baked goods, along with low-sodium salt, reduced-fat fried options, and both less-calorie and low-GI sugar alternatives. Furthermore, Holista CollTech offers solutions for infection control. Its corporate headquarters are located in Subiaco, Australia.
Holista Colltech Limited is most often compared with the following Healthcare names: